Fund Holdings — Prosight Management, LP

Total Portfolio Value:
$580.35M
Total Bought:
$155.66M
Total Sold:
$191.09M
Net Transaction:
-$35.43M
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Lakefront Biotherapeutics NVADR(LKFT)1,550,0002,043,344+493,344$46.50M$61.26M10.56%+$14.76M
Janux Therapeutics, Inc.(JANX)3,550,0003,804,481+254,481$49.34M$58.44M10.07%+$9.09M
Nektar Therapeutics(NKTR)735,000810,000+75,000$52.88M$56.55M9.74%+$3.66M
Boston Scientific Corporation(BSX)795,5471,270,273+474,726$49.92M$54.22M9.34%+$4.29M
Shattuck Labs, Inc.(STTK)5,004,4395,957,877+953,438$32.18M$41.35M7.12%+$9.17M
Insmed Incorporated(INSM)0375,609+375,609$0$40.05M6.90%+$40.05M
Alnylam Pharmaceuticals, Inc.(ALNY)76,00098,080+22,080$25.15M$29.53M5.09%+$4.38M
Syndax Pharmaceuticals, Inc.(SNDX)770,0001,200,000+430,000$17.99M$26.23M4.52%+$8.24M
Kura Oncology, Inc.(KURA)3,356,7002,021,964-1,334,736$27.29M$22.18M3.82%-$5.11M
Alkermes plcSHS(ALKS)513,632394,389-119,243$18.16M$20.66M3.56%+$2.50M
iRhythm Holdings, Inc.(IRTC)10,000165,500+155,500$1.18M$19.69M3.39%+$18.51M
Veeva Systems Inc.CL A(VEEV)86,480106,200+19,720$15.19M$18.85M3.25%+$3.66M
Zymeworks Inc.(ZYME)539,049674,434+135,385$13.50M$17.63M3.04%+$4.13M
ABIVAX Société AnonymeADS(ABVX)105,000107,394+2,394$11.69M$14.31M2.47%+$2.62M
Crinetics Pharmaceuticals In350,000374,666+24,666$12.71M$14.02M2.42%+$1.31M
Mineralys Therapeutics, Inc.(MLYS)0449,795+449,795$0$12.14M2.09%+$12.14M
ADC Therapeutics SASHS(ADCT)8,300,0007,824,749-475,251$31.13M$8.37M1.44%-$22.75M
ICU Medical, Inc.(ICUI)27,45051,000+23,550$3.55M$7.48M1.29%+$3.93M
Intuitive Surgical, Inc.(ISRG)4,00017,000+13,000$1.84M$6.76M1.16%+$4.92M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)697,108650,000-47,108$6.55M$6.10M1.05%-$448.8K
PROCEPT BioRobotics Corporation(PRCT)1,945,000268,269-1,676,731$48.64M$6.06M1.04%-$42.59M
GeneDx Holdings Corp.CL A(WGS)523,46385,500-437,963$33.62M$5.87M1.01%-$27.75M
Option Care Health, Inc.(OPCH)0270,716+270,716$0$5.68M0.98%+$5.68M
OnKure Therapeutics, Inc.CL A(OKUR)2,154,381978,992-1,175,389$8.92M$4.46M0.77%-$4.45M
Emergent BioSolutions Inc.(EBS)639,118459,952-179,166$5.30M$3.85M0.66%-$1.45M
Pfizer Inc.(PFE)0135,366+135,366$0$3.26M0.56%+$3.26M
OrthoPediatrics Corp.(KIDS)302,399157,500-144,899$4.80M$3.01M0.52%-$1.79M
Rocket Pharmaceuticals, Inc.(RCKT)683,856700,000+16,144$2.45M$2.39M0.41%-$54.2K
An2 Therapeutics Inc515,754474,638-41,116$1.76M$2.30M0.40%+$533.4K
Pliant Therapeutics, Inc.(PLRX)1,667,6001,370,233-297,367$2.10M$1.56M0.27%-$539.1K
Tectonic Therapeutic, Inc.(TECX)79,87239,731-40,141$2.47M$1.37M0.24%-$1.10M
MeiraGTx Holdings plc(MGTX)2,629,97190,000-2,539,971$22.78M$1.22M0.21%-$21.56M
Everforth, Inc.(EFOR)067,500+67,500$0$1.21M0.21%+$1.21M
Rein Therapeutics Inc.(RNTX)411,6001,100,000+688,400$535.1K$1.14M0.20%+$608.9K
Coya Therapeutics, Inc.(COYA)420,360170,000-250,360$1.66M$994.5K0.17%-$661.7K
Immuneering CorpCL A123,40936,861-86,548$650.4K$183.9K0.03%-$466.4K
Adicet Bio Inc250,2440-250,244$1.70M$0—-$1.70M
Concentra Group Holdings Parent, Inc.(CON)505,8220-505,822$10.85M$0—-$10.85M
Immunovant, Inc.(IMVT)175,8250-175,825$4.37M$0—-$4.37M
NovoCure Limited(NVCR)50,4000-50,400$549.4K$0—-$549.4K
Omeros Corporation(OMER)174,8000-174,800$1.85M$0—-$1.85M
Palvella Therapeutics, Inc.(PVLA)5,0000-5,000$623.3K$0—-$623.3K
Phreesia, Inc.(PHR)1,100,0000-1,100,000$9.22M$0—-$9.22M
REGENXBIO Inc.(RGNX)200,0000-200,000$1.68M$0—-$1.68M
Roivant Sciences Ltd.SHS(ROIV)180,0000-180,000$4.99M$0—-$4.99M
Schrödinger, Inc.(SDGR)510,5780-510,578$5.80M$0—-$5.80M
Terns Pharmaceuticals Inc202,3000-202,300$10.67M$0—-$10.67M
TransMedics Group, Inc.(TMDX)5,0000-5,000$497.1K$0—-$497.1K
TrueBlue, Inc.(TBI)249,1070-249,107$974.0K$0—-$974.0K
Upstream Bio, Inc.(UPB)241,1230-241,123$2.17M$0—-$2.17M
Viking Therapeutics, Inc.(VKTX)45,0000-45,000$1.46M$0—-$1.46M
Page 1 of 1